Table 1.
Basic characteristic | Patients with schizophrenia (n = 22) | Healthy people (n = 16) |
---|---|---|
Age (years ± SD) | 29.00 (8.05) | 27.44 (8.63) |
Male % (n) | 63.55 (14) | 43.75 (7) |
Education (years ± SD) | 13.14 (2.47) | 15.00 (2.58) |
MID (years ± SD) | 5.49 (4.05) | NA |
PANSS total | 53.64 (6.04) | NA |
PANSS positive | 14.86 (4.16) | NA |
PANSS negative | 11.45 (4.03) | NA |
PANSS general | 34.56 (9.62) | NA |
Medication | Patient Number | |
Typical | 5 | NA |
Atypical | 19 | NA |
Typical and atypicala | 2 | NA |
Chlorpromazine equivalent | Mean (SD): 521 (223) | NA |
Range: 225–1,000 |
MID, mean illness duration; NA, not applicable; PANSS, Positive and Negative Syndrome Scale; SD, standard deviation.
Two patients received both typical and atypical antipsychotic medications.